Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Supporting Coronavirus Research with Liquid Chromatography

The RNA in viruses such as SARS-CoV-2 are an ideal research target. RNA purification with liquid chromatography is essential in the fight against SARS-CoV-2.

From KNAUER Wissenschaftliche Geräte GmbH 5 Oct 2020

SGD Pharma extends industry-leading Ready-to-Use molded glass vial range with introduction of EasyLyo and ISO20mm 50ml sizes in tray

SGD Pharma extends leading glass vial range with new sizes

From SGD Pharma 2 Oct 2020

New commitments from governments and organizations support a unified approach to end pandemic

New commitments from governments, international organizations and the private sector support unified approach to end pandemic, backing a response of unprecedented scale, scope and speed-;through the Access to COVID-19 Tools Accelerator-;as pandemic claims more than 1 million lives

1 Oct 2020

Researchers unravel new mechanism of cell survival in chronic lymphocytic leukemia

Researchers at The Wistar Institute unraveled a mechanism employed by chronic lymphocytic leukemia (CLL) cells for their survival.

30 Sep 2020

Investigational mRNA vaccine to prevent SARS-CoV-2 shows promise in older adults

A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults.

30 Sep 2020

Sky-high drug prices driven by pharma profits, House Dems charge

Enormous drug company profits are the primary driver of soaring prescription drug prices in America, according to a damning investigation that Democrats on the House Oversight Committee began releasing Wednesday.

30 Sep 2020

A TLR2 agonist reduces SARS-CoV-2 in upper respiratory tract of ferret model

In a recent bioRxiv* preprint paper, Professor Miles W. Carroll et al. study an agonist for reducing the SARS-CoV-2's viral load. They show that prophylactic intra-nasal administration of TLR2/6 (toll-like receptor) agonist, INNA-051, reduces viral RNA in the nose and throat, in a ferret model.

30 Sep 2020

Abacus Diagnostica's new multiplex assay provides reliable influenza, COVID-19 diagnosis in 75 minutes

Abacus Diagnostica is a small Finnish company developing and manufacturing assays and devices for rapid molecular diagnostics. Since the beginning of COVID-19 outbreak the company has worked decisively on the development of SARS-CoV-2 diagnostics.

30 Sep 2020

Researchers report promising preclinical findings for a prototype of vascular graft

In a proof-of-concept study, North Carolina State University researchers reported promising preclinical findings for a prototype of a vascular graft designed as a replacement for a damaged or blocked coronary artery, which supplies blood to the heart.

30 Sep 2020

Jellagen announces collaboration with Mayo Clinic

Jellagen has entered into a license agreement for an exclusive grant to patent rights with Mayo Clinic for the development in treatment of vocal cord paralysis.

29 Sep 2020

3D-printed alternative performs as well as the standard nasal swabs for COVID-19 testing

As COVID-19 quickly spread worldwide this spring, shortages of supplies, including the nasopharyngeal (nasal) swabs used to collect viral samples, limited diagnostic testing.

25 Sep 2020

New diagnostic tool may allow on-the-spot detection of coronavirus infection

Scientists at the University of Warwick have demonstrated that a potential diagnostic tool for detecting Covid-19 using sugars will work with a virus rather than just its proteins, a significant step in making it a viable test in future.

25 Sep 2020

ZwickRoell’s zwickiLine Testing System Validated for Cleanroom Use

The importance of cleanrooms is currently in the spotlight as the global community awaits a vaccine for Covid-19.

25 Sep 2020

BIOCAD to produce liquid vaccine for COVID-19 treatment

Clinical trials of the vaccine are currently underway. The &laquoSputnik V» is the two-component vaccine. Revaccination is carried out at intervals of 3-4 weeks. Moreover, with the repeated introduction of a particle of coronavirus RNA, it is covered with a new adenovirus.

25 Sep 2020